Development of multi-algorithm machine learning models integrating novel serum biomarkers for survival prediction in colorectal cancer: a retrospective cohort study - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Creation of Collaborative Machine Learning Models Incorporating Innovative Serum Biomarkers for Survival Forecasting in Colorectal Cancer: A Retrospective Cohort Analysis

  • By

  • Hailun Xie

  • Lishuang Wei

  • Taiqi Chen

  • Shuangyi Tang

  • Jialiang Gan

  • September 15, 2026

Share

Clinical Report: Collaborative Machine Learning Models for CRC Survival Forecasting

Overview

This study developed a collaborative machine learning approach to identify key prognostic factors in colorectal cancer (CRC) patients, integrating clinical, pathological, serological, and demographic variables.

Background

Colorectal cancer (CRC) presents significant challenges in prognostic prediction due to tumor heterogeneity and limitations of the conventional TNM staging system. Accurate prognostic tools are essential for tailoring individualized treatment strategies.

Data Highlights

FeatureType
M stagePathological
N stagePathological
Cystatin CSerological
HomocysteineSerological
γ-Glutamyl TransferaseSerological
AgeDemographic

Key Findings

  • Six central prognostic features identified: M stage, N stage, Cystatin C, Homocysteine, γ-Glutamyl Transferase, and age.
  • Cox regression confirmed independent associations of these features with overall survival (OS) and progression-free survival (PFS).
  • Nomograms for OS and PFS demonstrated calibration and discrimination (OS C-index: 0.730; PFS C-index: 0.722).
  • AUCs for OS and PFS exceeded 75% and 77%, respectively.
  • Decision curve analysis indicated clinical utility compared to conventional pathological staging.
  • Internal validation confirmed predictive performance of the nomograms.

Clinical Implications

The integration of multiple prognostic factors into nomograms may enhance survival predictions for CRC patients.

Conclusion

This study presents collaborative machine learning models for prognostic prediction in colorectal cancer.

Related Resources & Content

  1. Frontiers in Oncology, 2026 -- Prognostic Prediction of Colorectal Cancer Utilizing Multi-Faceted Biomarker Characteristics and Machine Learning Approaches
  2. Frontiers in Oncology, 2026 -- Survival prediction in colorectal cancer liver metastases using machine learning with SHAP-based interpretation
  3. Journal of Medical Internet Research (JMIR), 2026 -- Evaluation of the Applicability of Synthetic Data in the Development of Colorectal Cancer Survival Prediction Models: External Validation of Advanced Machine Learning Models Based on National Cancer Data Center Data
  4. Frontiers in Oncology, 2026 -- Development and assessment of machine learning algorithms for predicting postoperative outcomes in biliary tract cancers
  5. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up - PubMed
  6. Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline
  7. The prognostic role of circulating CA19-9 and CEA in patients with colorectal cancer - PubMed
  8. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up - PubMed
  9. Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline
  10. The prognostic role of circulating CA19-9 and CEA in patients with colorectal cancer - PubMed

Original Source(s)

Related Content